This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
In August 2022, the European Medicines Agency granted Marketing Authorization to lenacapavir (Sunlenca), the first-in-class bi-annually dosed HIV capsid inhibitor…
Article
4 months ago ●
6 mins read
Revisiting AMPK activation with β2-AMPK isoform potency. “Compound 14d” (Shionogi & Co.) is a highly potent, dose-dependent adenosine monophosphate activated…
molecule
1 month ago ●
4 mins read
We did a deep dive into the pharmaceutical industry’s 2022Q2/Q3 news, and there’s a ton of exciting updates to share.…
Article
4 months ago ●
14 mins read
sAC as a target for male contraception. Soluble adenylyl cyclase (sAC) is one of several ACs that catalyze the cyclization…
molecule
1 month ago ●
4 mins read
Our team conducted a review of all the biotech acquisitions of 2021 and distilled it down to the acquisitions of…
Article
4 months ago ●
6 mins read
WASp as a new target for hematological cancers. Wiskott-Aldrich syndrome protein (WASp) is a protein almost exclusively expressed in hematopoetic…
molecule
1 month ago ●
3 mins read
Load More
